Company news

West Pharmaceutical Services, Inc. news in 2026

West Pharmaceutical Services, Inc.'s news releases, calls and decks from 2026, newest first.

View company

West to Participate in Upcoming Investor Conference

November 4, 2026

West Reports Third-Quarter 2026 Results

October 29, 2026

West Declares Quarterly Dividend

October 19, 2026

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

October 5, 2026

West Reports Second-Quarter 2026 Results

July 23, 2026

West to Host Second-Quarter 2026 Conference Call

July 7, 2026

West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System

July 1, 2026

West Appoints Michel Lagarde to be President and Chief Executive Officer

June 1, 2026

West Reports First-Quarter 2026 Results

April 23, 2026

West to Host First-Quarter 2026 Conference Call

April 9, 2026

West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity

March 31, 2026

Global IV Infusion Bottle Seals & Caps Market to Hit USD 7.3Bn by 2035 | Asia Pacific | West Pharma, Aptar, Gerresheimer

March 30, 2026

Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.

March 9, 2026

West Announces Quarterly Dividend and Share Repurchase Program

February 17, 2026

West Reports Fourth-Quarter and Full-Year 2025 Results

February 12, 2026

West to Host Fourth-Quarter and Full-Year 2025 Conference Call

January 29, 2026

West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack

January 20, 2026

West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

January 12, 2026

Calls in 2026

Decks in 2026